NCT06579677 PRospective Observation on CErebral microvaScular Structure and Function
| NCT ID | NCT06579677 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Beijing Tiantan Hospital |
| Condition | Cerebral Microvascular Dysfunction |
| Study Type | OBSERVATIONAL |
| Enrollment | 3,500 participants |
| Start Date | 2024-10-18 |
| Primary Completion | 2032-03 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 3,500 participants in total. It began in 2024-10-18 with a primary completion date of 2032-03.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a population-based prospective cohort study, aiming to assess the prevalence, distributional characteristics, and dynamic change of cerebral small vessel dysfunction in a Chinese community population using advanced vascular imaging techniques; meanwhile to investigate the effect of vascular risk factors on cerebral small vessel dysfunction, cardiovascular and cerebrovascular diseases, cognitive dysfunction, and mortality.
Eligibility Criteria
Inclusion Criteria: 1. Community-dwelling adults aged 50-75 years; 2. Registered Beijing household residents or residents who can be followed up stably in their own communities for a long period; 3. Subjects with written informed consents. Exclusion Criteria: 1. Residents with moderate to severe disabilities (MRS ≥3), mental illness, stroke, dementia, and other serious neurological disorders (e.g., encephalitis, Parkinson's disease, epilepsy, brain tumors, and rare genetic diseases of the nervous system); 2. Life expectancy of ≤4 years due to serious diseases such as end-stage cancer; 3. Contraindications to magnetic resonance imaging such as implanted devices (e.g., pacemakers, defibrillators, and others); 4. Residents who are participating in other studies.
Contact & Investigator
Yilong Wang, MD, PhD
PRINCIPAL INVESTIGATOR
Beijing Tiantan Hospital
Frequently Asked Questions
Who can join the NCT06579677 clinical trial?
This trial is open to participants of all sexes, aged 50 Years or older, up to 75 Years, studying Cerebral Microvascular Dysfunction. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06579677 currently recruiting?
Yes, NCT06579677 is actively recruiting participants. Contact the research team at panys2000@163.com for enrollment information.
Where is the NCT06579677 trial being conducted?
This trial is being conducted at Beijing, China, Beijing, China.
Who is sponsoring the NCT06579677 clinical trial?
NCT06579677 is sponsored by Beijing Tiantan Hospital. The principal investigator is Yilong Wang, MD, PhD at Beijing Tiantan Hospital. The trial plans to enroll 3,500 participants.